Alkermes plc today announced plans to present new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1) at the American Academy of Neurology (AAN) 2026 ...
Smart rings and watches are designed to be small, compact, and comfortable. One brain wearable company, Neurable, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results